Oxidative Medicine and Cellular Longevity, 2021 · DOI: https://doi.org/10.1155/2021/1695087 · Published: August 26, 2021
Traumatic spinal cord injury (SCI) is a devastating condition that can lead to long-term disability. This study explores the potential of microglia-derived exosomes (MG-Exos) to aid in recovery after SCI. The research investigates whether MG-Exos can protect spinal cord microvascular endothelial cells (SCMECs) from oxidative stress, which is known to hinder the natural repair processes after SCI. The study also examines how MG-Exos impact vascular regeneration and cell proliferation, as well as functional recovery, in a mouse model of SCI, aiming to verify the therapeutic capabilities of MG-Exos.
MG-Exos may represent a novel therapeutic approach for promoting spinal cord functional recovery after injury.
The activation of the keap1/Nrf2/HO-1 signaling pathway by MG-Exos provides a potential mechanism for reducing oxidative stress in SCI.
The ability of MG-Exos to promote vascular regeneration may be crucial for providing the necessary support for spinal cord repair.